Maravai LifeSciences Holdings, Inc. Payments of Ordinary Dividends, Noncontrolling Interest
Maravai LifeSciences Holdings, Inc. (MRVI) reported Payments of Ordinary Dividends, Noncontrolling Interest of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividendsMinorityInterest · last filed 2025-11-07
- Maravai LifeSciences Holdings, Inc. payments of ordinary dividends, noncontrolling interest for the quarter ending 2025-09-30 was $0.00.
- Maravai LifeSciences Holdings, Inc. payments of ordinary dividends, noncontrolling interest for the quarter ending 2024-12-31 was -$78.00K.
- Maravai LifeSciences Holdings, Inc. payments of ordinary dividends, noncontrolling interest for the quarter ending 2024-09-30 was $0.00.
- Maravai LifeSciences Holdings, Inc. payments of ordinary dividends, noncontrolling interest for the quarter ending 2024-06-30 was $572.00K, a 56.17% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. payments of ordinary dividends, noncontrolling interest for fiscal 2024 was $494.00K, a 94.86% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. payments of ordinary dividends, noncontrolling interest for fiscal 2023 was $9.61M, a 93.60% decline from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. payments of ordinary dividends, noncontrolling interest for fiscal 2022 was $150.21M, a 2.11% decline from fiscal 2021.
- Maravai LifeSciences Holdings, Inc. payments of ordinary dividends, noncontrolling interest for fiscal 2021 was $153.45M, a 58.11% increase from fiscal 2020.
| Period end | Payments of Ordinary Dividends, Noncontrolling Interest 3 month | Payments of Ordinary Dividends, Noncontrolling Interest 6 month | Payments of Ordinary Dividends, Noncontrolling Interest 9 month | Payments of Ordinary Dividends, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-11 | |||
| 2024-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$78.00K derived: sum of 2 quarters · filed 2025-11-07 | $494.00K derived: sum of 3 quarters · filed 2025-11-07 | $494.00K 10-K · filed 2025-03-18 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $572.00K derived: sum of 2 quarters · filed 2025-11-07 | $572.00K 10-Q · filed 2025-11-07 | $572.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $572.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $572.00K 10-Q · filed 2025-08-11 | $572.00K derived: sum of 3 quarters · filed 2025-08-11 | $572.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $0.00 derived: sum of 3 quarters · filed 2025-03-18 | $1.30M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $0.00 derived: sum of 2 quarters · filed 2025-03-18 | $1.30M derived: sum of 3 quarters · filed 2025-03-18 | $9.61M 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.30M derived: sum of 2 quarters · filed 2024-11-12 | $9.61M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $9.61M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $8.30M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $150.21M 10-K · filed 2025-03-18 | |||
| 2021-12-31 | $153.45M 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $97.05M 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 |